Literature DB >> 2683247

Stroke in the People's Republic of China.

F L Shi1, R G Hart, D G Sherman, C H Tegeler.   

Abstract

Recent epidemiologic studies confirm that stroke is the most frequent cause of death in the People's Republic of China, with an incidence (219/100,000 people) more than fivefold that of myocardial infarction. Intracerebral hemorrhage causes about one third of all strokes, nearly three times the frequency in North American stroke registries. A marked regional variation in stroke incidence exists, with a threefold higher stroke incidence in northern than in southern Chinese cities, suggesting important environmental or dietary influences. Stroke treatment often involves a combination of modern and traditional herbal medicine; the latter may modify platelet aggregation and blood viscosity. Stroke, particularly intracerebral hemorrhage, is the most frequent and important vascular disorder in the People's Republic of China.

Entities:  

Mesh:

Year:  1989        PMID: 2683247     DOI: 10.1161/01.str.20.11.1581

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Haemostatic changes during surgery for primary brain tumours.

Authors:  K Y Goh; W C Tsoi; C S Feng; N Wickham; W S Poon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

2.  Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients.

Authors:  Yi Li; Han-xu Xi; Sha Zhu; Na Yu; Jing Wang; Yan Li; Guo-pei Yu; Xie-min Ma; Jun Zhang; Lue-ping Zhao
Journal:  Chin J Integr Med       Date:  2014-08-05       Impact factor: 1.978

Review 3.  Cost-effective intervention in stroke.

Authors:  D Dunbabin
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

Review 4.  Stroke in central nervous system infections.

Authors:  Francisco Javier Carod-Artal
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

5.  Cerebral haemorrhage in a French prospective population study.

Authors:  M Giroud; P Gras; N Chadan; P Beuriat; C Milan; P Arveux; R Dumas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

6.  A functional variant in promoter region of platelet-derived growth factor-D is probably associated with intracerebral hemorrhage.

Authors:  Yongyi Bai; Jingzhou Chen; Kai Sun; Yibo Wang; Rutai Hui
Journal:  J Neuroinflammation       Date:  2012-01-30       Impact factor: 8.322

7.  Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individuals.

Authors:  Wenjing Ou; Xin Liu; Yue Shen; Jiana Li; Lingbin He; Yuan Yuan; Xuerui Tan; Lisheng Liu; Jingbo Zhao; Xingyu Wang
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

8.  Underlying Cause of Death Recorded during 2013 to 2015 at a Tertiary General Hospital in Vientiane Capital, Lao PDR.

Authors:  Bounfeng Phoummalaysith; Viengsakhone Louangpradith; Tavanh Manivon; Bounxou Keohavong; Eiko Yamamoto; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

9.  Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults.

Authors:  Yuanli Dong; Xukui Liu; Yingxin Zhao; Qiang Chai; Hua Zhang; Yumei Gao; Zhendong Liu
Journal:  Front Cardiovasc Med       Date:  2021-06-17

10.  Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE).

Authors:  Penglian Wang; Yongjun Wang; Tao Feng; Xingquan Zhao; Yong Zhou; Yilong Wang; Weixiong Shi; Yi Ju
Journal:  BMC Neurol       Date:  2012-09-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.